17-(allylamino)-17-demethoxy-geldanamycin,
17-(allylamino)-17-demethoxygeldanamycin,
17-AAG,
17-allyl-aminogeldanamycin,
17-allylamino-17-demethoxygeldanamycin,
17-allylamino-17-demethoxygeldanamycin hydroquinone,
17-allylamino-17-demethoxygeldanamycin hydroquinone salt,
17-allylamino-geldanamycin,
17-allylaminogeldanamycin,
17AAG,
CNF1010,
IPI 493,
IPI 504,
IPI-493,
IPI-504,
IPI493,
IPI504,
NSC 330507,
NSC-330507,
retaspimycin hydrochloride,
tanespimycin,
Tanespimycin,
17-AAG,
17-Allylaminogeldanamycin,
75747-14-7,
17-(Allylamino)geldanamycin,
NSC-330507,
17-Demethoxy-17-allylamino geldanamycin,
KOS-953,
UNII-4GY0AVT3L4,
17-(Allylamino)-17-demethoxygeldanamycin,
17AAG,
CHEBI:64153,
17-AAG (Tanespimycin),
BMS-722782,
4GY0AVT3L4,
17-AG,
Cp 127374,
NSC 330507,
MFCD04973892,
NCGC00163424-01,
17-N-allylamino-17-demethoxygeldanamycin,
Geldanamycin, 17-demethoxy-17-(2-propenylamino)-,
NSC330507,
Tanespimycin (USAN),
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate,
[(3S,5S,6R,7S,8E,10R,11S,12E,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate,
Geldanamycin, 17-(Allylamino)-17-demethoxy-,
17-demethoxy-17-(2-propenylamino)geldanamycin,
Tanespimycin [USAN:INN],
KOS 953,
tanespimycina,
tanespimycine,
tanespimycinum,
CCRIS 9401,
17-Demethoxy-17-allylaminogeldanamycin,
C31H43N3O8,
17-AAG(Geldanamycin),
AC1O6S9N,
DSSTox_CID_26352,
DSSTox_RID_81555,
DSSTox_GSID_46352,
BSPBio_001434,
SCHEMBL2604976,
DTXSID5046352,
SCHEMBL13037468,
SCHEMBL16226295,
CHEBI:94756,
CNF-101,
AYUNIORJHRXIBJ-TXHRRWQRSA-N,
HMS1361H16,
HMS1791H16,
HMS1989H16,
HMS3402H16,
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16- tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa- 1(21),4,6,10,18-penten-9-yl carbamate,
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate,
NSC-330507D,
Tox21_112054,
BDBM50008057,
s1141,
AKOS024456643,
ZINC100014666,
BCP9000064,
CCG-208039,
CS-0161,
DB05134,
NSC-704057,
RL04887,
IDI1_033904,
NCGC00163424-02,
NCGC00163424-04,
NCGC00163424-05,
NCGC00163424-06,
NCGC00163424-07,
CP127374,
HY-10211,
SC-22451,
Geldanamycin, des-O-methyl-17-allylamino-,
AB2000717,
CAS-75747-14-7,
CP-127374,
Geldanamycin, 17-allylamino-17-demethoxy-,
CP127374,NSC-330507,
X7553,
D06650,
W-5317,
747A147,
Geldanamycin,17-demethoxy-17-(2-propenylamino)-,
J-504153,
BRD-K81473043-001-03-9,
BRD-K81473043-001-08-8,
CP 127374, 75747-14-7,
17-(Allylamino)-17-demethoxygeldanamycin, >=98% (HPLC), solid,
17-Demethoxy-17-allylaminogeldanamycin; Tanespimycin; 17-Allylaminogeldanamycin,
(8S,9S,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate,
[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(allylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate,
[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate,
17-AAG|||17-(Allylamino)-17-demethoxy-geldanamycin|||[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate,
Telatinib,
geldanamycin,
Tanespimyci,
Tanespimycin [USAN],
D0XV0T,
CHEMBL109480,
GLD-36,
C31-H43-N3-O8,
CID6505803,
17-allylamino-17-desmethoxy-geldanamycin,
2-Azabicyclo[16.3.1]docosane, geldanamycin deriv.,
AAG,
17-(Allylamino)geldanamycin; 17-Demethoxy-17-allylamino geldanamycin; 17-AAG; CP 127374; Geldanamycin,17-demethoxy-17-(2-propenylamino)-; NSC 330507; Tanespimycin,